Skip to main content
Elsevier

Nanoengineered Therapeutics for Lung Cancer

Advanced Drug Delivery Strategies

  • 1st Edition - October 1, 2026
  • Latest edition
  • Editors: Arun Kumar Singh, Meenakshi Dhanawat, Shikha Baghel Chauhan, Indu Singh, Neeraj Kumar
  • Language: English

Nanoengineered Therapeutics for Lung Cancer: Advanced Drug Delivery Strategies explores contemporary methods for diagnosing and treating lung cancer using cutting-edge nanote… Read more

Back to School

Start strong. Study with purpose.

Save up to 25% on trusted learning resources

Shop now

Description

Nanoengineered Therapeutics for Lung Cancer: Advanced Drug Delivery Strategies explores contemporary methods for diagnosing and treating lung cancer using cutting-edge nanotechnology. The book provides a foundational understanding of lung cancer biology, detailing innovative nanodrug delivery strategies and their practical applications in treatment. The content is strategically structured, covering the design, synthesis, and application of nanodrug delivery systems. Chapters delve into specific technologies such as gold nanoparticles, exosome-mediated therapies, and siRNA-based gene silencing. The book also addresses challenges like drug resistance and toxicity, offering insights into future research directions and advancements in the field. This book benefits graduate students, researchers, and healthcare professionals by seamlessly integrating theoretical concepts with practical applications. It serves as an essential educational resource, equipping readers with the knowledge and skills needed to tackle complex challenges in lung cancer treatment using nanomedicine. This comprehensive guide ensures that readers stay at the forefront of the rapidly evolving landscape of cancer therapeutics.

Key features

  • Provides a thorough examination of the design, synthesis, and application aspects of nanodrug delivery systems
  • Introduces groundbreaking and advanced methodologies for diagnosing and treating lung cancer
  • Highlights how strategic design methodologies significantly enhance therapeutic efficacy, leading to more effective and targeted lung cancer treatments

Readership

Postgraduate students, early-career researchers, and healthcare professionals in the fields of oncology, nanotechnology, pharmacology, and biomedical science

Table of contents

1. Introduction to Nanomedical Drug Delivery for Lung Cancer

2. An Overview of the Anatomy and Physiology of Lung Cancers

3. Nanoparticle Advancements in Lung Cancer: Cutting-edge Diagnosis and Therapy Approaches

4. Revolutionizing Lung Cancer Treatment: Nanoengineered Enhancements in Targeted Drug Delivery for Enhanced Efficacy

5. Exosome-Mediated Precision Targeting: A Paradigm Shift in Lung Cancer Theranostics

6. Exosome-Mediated Precision Immunotherapy in Lung Cancer: Harnessing Smart Drug Delivery Vehicles

7. Gold Nanoparticles in the Battle Against Lung Cancer: Biomedical Applications and Therapeutic Innovations

8. Nanoparticle Chemotherapy via Pulmonary Route: Addressing Challenges, Exploring Opportunities in Lung Cancer Treatment

9. Targeted Therapeutics: Harnessing Polymeric Nanoparticles for Lung Cancer Treatment

10. Solid Lipid Nanoparticles: Revolutionizing Lung Cancer Therapy Through Targeted Drug Delivery

11. Dendrimers: Promising Nanocarriers for Targeted Delivery in Lung Cancer Treatment

12. Targeting Lung Cancer: Aerosol Delivery of Star Polymer-siRNA Nanoparticles for Tumor Inhibition

13. Revolutionizing Lung Cancer Immunotherapy: siRNA-Based Gene Silencing for Immune Checkpoint Blockade

14. Overcoming Drug Resistance in Non-Small Cell Lung Cancer: siRNA-Guided Gene Silencing Combined with Cisplatin Therapy

15. Navigating Toxicity in Lung Cancer Immunotherapy: Challenges and Advances in Nanomedicine Drug Delivery

16. Nanotechnology in Lung Cancer Therapy: Recent Advancements and Future Perspectives in Drug Delivery Systems

17. Conclusion: Future Directions and Emerging Trends in Nanomedical Drug Delivery for Lung Cancer

Product details

  • Edition: 1
  • Latest edition
  • Published: October 1, 2026
  • Language: English

About the editors

AS

Arun Kumar Singh

Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies.
Affiliations and expertise
Assistant Professor, University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, Tehsil Kharar, Distt. Mohali, Punjab, India

MD

Meenakshi Dhanawat

Dr. Meenakshi Dhanawat is an Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, with over 18 years of experience in Pharmaceutical Sciences and Medicinal Chemistry. She completed her Master's degree at NIPER, Mohali, focusing on glycosylamino acids, and earned her Ph.D. from IIT-BHU, Varanasi, investigating CNS drug delivery targeting 5HT1A/2A receptors. Her research encompasses synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, complexation, polymer chemistry, and herbal drug extraction. Dr. Dhanawat has received notable international recognition, including a travel grant from the AAPS Drug Delivery and Development section for the 2010 National Biotechnology Conference in California, and international travel grants from DBT and DST, Government of India, for conferences in California and Munich. Her distinguished honors include the Rajiv Gandhi National Fellowship, affirming her sustained contributions to pharmaceutical research and academic excellence.
Affiliations and expertise
Associate Professor, Amity Institute of Pharmacy, Amity University, Haryana, India

SC

Shikha Baghel Chauhan

Dr Shikha Baghel Chauhan is working as Associate Professor in Department of Industrial Pharmacy, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh. She has over 2 decades of experience in both academia and the pharmaceutical industry. She holds a PhD in Pharmaceutics from Amity University, Noida. She is the founder of the popular pharmacy YouTube channel ‘Pharmacypedia’. She has published 52 research papers in various international and national journals and has served as the editor of two books with international publishers. She has been granted two patents and has authored nine books with different national and international publishers. Additionally, she has written over 15 book chapters for many prestigious publishers. Her key research areas include Novel Drug Delivery Systems, Transdermal Drug Delivery Systems, Nano Lipid Carriers, and Herbal Drug Development

Affiliations and expertise
Amity Institute of Pharmacy, India

IS

Indu Singh

Dr. Indu Singh is currently serving as an Assistant Professor at the Centre of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh. Previously, she worked as an Assistant Professor in the Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar Central University, Lucknow.

She has over nine years of post-PhD teaching experience and holds a Bachelor of Pharmacy (B. Pharm.), Master of Pharmacy (M. Pharm.), and Doctor of Philosophy (Ph.D.) in Pharmaceutics. She completed her Ph.D. at the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, under the Government of India, in the area of Nanomedicines specifically on bioconjugated nanotherapeutics for tumor targeting.

A gold medalist in both her B. Pharm. and M. Pharm. programs, Dr. Singh was awarded the GATE and GPAT scholarship by the Ministry of Human Resource Development (MHRD) for her M. Pharm. and the Research Fellowship from the Ministry of Chemicals and Fertilizers, Government of India for her Ph.D. studies. She is a registered pharmacist with the Pharmacy Council of India through the Uttar Pradesh Pharmacy Council, Lucknow.

In 2015, she qualified the Women Scientist-C (WOS-C) examination (KIRAN-IPR) conducted by the Department of Science and Technology (DST), New Delhi. She also received the Young Scientist International Travel Grant from the Council of Scientific and Industrial Research (CSIR), India, to attend the 6th International Conference on Nanomaterials-Research & Application (NANOCON-2014) held in Brno, Czech Republic (EU).

Dr. Singh has received numerous awards for her oral and poster presentations at various national and international conferences. She has published over 70 research papers in reputed international journals with high impact factors, authored 20 book chapters, and written four Scopus-indexed books. Additionally, she has filed four patents, with one patent already granted to her credit. She was the invited speaker for IBRO-APRC Associate School in November 2022.
Affiliations and expertise
Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India

NK

Neeraj Kumar

Dr. Niraj Kumar Jha is an Assistant Professor of Biotechnology at Galgotias University, India, with prior research affiliations at the Centre for Research Impact & Outcome (CRIO), Chitkara University, and Sharda University. His research portfolio encompasses over 200 peer-reviewed articles and scholarly reviews, along with an edited volume published by Springer, reflecting sustained contributions to biomedical research and translational science. According to Scopus metrics, Dr. Jha’s publications have garnered more than 10,000 citations, with an H-index exceeding 50, underscoring the broad impact and visibility of his work within the global scientific community. He is an elected Member of the Royal Society of Biology (MRSB), London, and has been recognized among the World’s Top 2% Scientists in rankings compiled by Elsevier in collaboration with Stanford University. Dr. Jha actively contributes to scientific publishing and peer review as an associate editor for the Journal of Alzheimer’s Disease (IOS Press) and IET Nanobiotechnology (Wiley) and serves on the editorial boards of several international journals, including Scientific Reports. His research is centered on elucidating the molecular and cellular mechanisms underlying complex diseases such as neurodegenerative disorders, cancer, and cardiovascular pathologies. His work particularly emphasizes the modulation of key signaling pathways and explores the therapeutic potential of natural products, phytochemicals, and synthetic small molecules in disease intervention.
Affiliations and expertise
Department of Biotechnology and Bioengineering, School of Biosciences and Technology, Galgotias University, Greater Noida, Uttar Pradesh, India